IL87517A - Process for preparing an enantiomeric mixture of erythro and threo lactones - Google Patents

Process for preparing an enantiomeric mixture of erythro and threo lactones

Info

Publication number
IL87517A
IL87517A IL87517A IL8751788A IL87517A IL 87517 A IL87517 A IL 87517A IL 87517 A IL87517 A IL 87517A IL 8751788 A IL8751788 A IL 8751788A IL 87517 A IL87517 A IL 87517A
Authority
IL
Israel
Prior art keywords
erythro
preparing
enantiomeric mixture
difluoronucleosides
deoxy
Prior art date
Application number
IL87517A
Other languages
English (en)
Other versions
IL87517A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to IL10214488A priority Critical patent/IL102144A/en
Publication of IL87517A0 publication Critical patent/IL87517A0/xx
Priority to IL102143A priority patent/IL102143A0/xx
Priority to IL102144A priority patent/IL102144A0/xx
Publication of IL87517A publication Critical patent/IL87517A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Epoxy Compounds (AREA)
IL87517A 1987-08-28 1988-08-22 Process for preparing an enantiomeric mixture of erythro and threo lactones IL87517A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL10214488A IL102144A (en) 1987-08-28 1988-08-22 Process for the preparation of '2 - deoxy -' 2, '2 - difluoro nucleosides
IL102143A IL102143A0 (en) 1987-08-28 1992-06-09 Process for selectively isolating 2-deoxy-2,2-difluoro-d-erythro-pentofuranos-1-ulose-3,5-dibenzoate
IL102144A IL102144A0 (en) 1987-08-28 1992-06-09 Process for producing 2'-deoxy-2',2'-difluoro nucleosides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9072587A 1987-08-28 1987-08-28

Publications (2)

Publication Number Publication Date
IL87517A0 IL87517A0 (en) 1989-01-31
IL87517A true IL87517A (en) 1993-05-13

Family

ID=22224017

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87517A IL87517A (en) 1987-08-28 1988-08-22 Process for preparing an enantiomeric mixture of erythro and threo lactones

Country Status (11)

Country Link
EP (4) EP0688782B1 (fr)
JP (5) JP2738540B2 (fr)
KR (1) KR970002659B1 (fr)
AT (4) ATE202113T1 (fr)
CA (1) CA1324128C (fr)
DE (4) DE3856527T2 (fr)
ES (4) ES2157289T3 (fr)
GR (1) GR3026611T3 (fr)
HU (3) HU202249B (fr)
IE (1) IE81131B1 (fr)
IL (1) IL87517A (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2012129A1 (fr) * 1989-03-20 1990-09-20 Ramakrishnan Nagarajan Recuperation de sucre difluore
US5401861A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
US5256798A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
US5252756A (en) * 1992-06-22 1993-10-12 Eli Lilly And Company Process for preparing beta-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl-arylsulfonates
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
US5256797A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for separating 2-deoxy-2,2-difluoro-D-ribofuranosyl alkylsulfonate anomers
US5559222A (en) * 1995-02-03 1996-09-24 Eli Lilly And Company Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose
AU1289697A (en) 1995-12-13 1997-07-03 Eli Lilly And Company Alpha, alpha-difluoro-beta-hydroxy thiol esters and their synthesis
KR100578616B1 (ko) * 2004-07-23 2006-05-10 한미약품 주식회사 Ｄ-에리트로-2,2-다이플루오로-2-데옥시-1-옥소라이보스화합물의 제조방법
EP1940859A1 (fr) * 2005-10-28 2008-07-09 Arch Pharmalabs Limited Procede ameliore de preparation de gemcitabine hydrochlorure
JP2009519325A (ja) * 2005-12-14 2009-05-14 ドン−エー ファーム．カンパニー リミテッド ２’、２’−ジフルオロヌクレオシドと中間体の製造プロセス
KR100741310B1 (ko) * 2006-08-01 2007-08-01 (주) 유일팜테크 젬시타빈의 합성에 유용한 신규한나프탈렌-2-카르복실레이트 유도체와 그의 제조방법
US7994310B2 (en) * 2007-03-23 2011-08-09 Dongwoo Syntech Co., Ltd. Process for preparing 2′-deoxy-2′, 2′-difluorocytidine
CA2727813A1 (fr) * 2008-06-12 2009-12-17 Scinopharm Taiwan, Ltd. Polymorphes cristallins de la base gemcitabine
GB0812895D0 (en) * 2008-07-15 2008-08-20 Glycom As Crystalline carbohydrate derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
EP0184365B1 (fr) * 1984-12-04 1993-08-04 Eli Lilly And Company Traitement de tumeurs chez les mammifères
CA1295998C (fr) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides et leur utilisation en tant qu'agents antineoplasiques

Also Published As

Publication number Publication date
HU906268D0 (en) 1991-03-28
DE3856477T2 (de) 2001-11-08
DE3856477D1 (de) 2001-07-19
ES2131152T3 (es) 1999-07-16
ATE164847T1 (de) 1998-04-15
ATE202113T1 (de) 2001-06-15
ES2157289T3 (es) 2001-08-16
HU9201768D0 (en) 1992-08-28
IE81131B1 (en) 2000-03-22
JP2899576B2 (ja) 1999-06-02
EP0688782B1 (fr) 2002-05-02
IL87517A0 (en) 1989-01-31
HU202249B (en) 1991-02-28
KR970002659B1 (ko) 1997-03-07
GR3026611T3 (en) 1998-07-31
JP2777359B2 (ja) 1998-07-16
JP2738540B2 (ja) 1998-04-08
EP0630905B1 (fr) 1999-05-06
ES2176279T3 (es) 2002-12-01
DE3856527T2 (de) 2002-10-31
HU206886B (en) 1993-01-28
JPH1072484A (ja) 1998-03-17
JPS6471894A (en) 1989-03-16
IE882608L (en) 1989-02-28
EP0306190A2 (fr) 1989-03-08
HUT47590A (en) 1989-03-28
DE3856527D1 (de) 2002-06-06
EP0306190B1 (fr) 1998-04-08
ATE217009T1 (de) 2002-05-15
JPH1072457A (ja) 1998-03-17
DE3856158T2 (de) 1998-08-20
CA1324128C (fr) 1993-11-09
EP0688783A1 (fr) 1995-12-27
DE3856330D1 (de) 1999-06-10
JP2810034B2 (ja) 1998-10-15
DE3856330T2 (de) 1999-09-30
JPH1072483A (ja) 1998-03-17
ES2113845T3 (es) 1998-05-16
EP0688783B1 (fr) 2001-06-13
DE3856158D1 (de) 1998-05-14
ATE179713T1 (de) 1999-05-15
EP0306190A3 (fr) 1991-11-21
JP2899577B2 (ja) 1999-06-02
KR890003794A (ko) 1989-04-18
JPH1081696A (ja) 1998-03-31
EP0688782A1 (fr) 1995-12-27
EP0630905A1 (fr) 1994-12-28

Similar Documents

Publication Publication Date Title
IL87517A (en) Process for preparing an enantiomeric mixture of erythro and threo lactones
CA2295515A1 (fr) Procede de production de masse de di(uridine 5'-tetraphosphate) et de ses sels
MY102581A (en) Process for production of avermectins and cultures therefor
EP0187680A3 (en) Process for producing organic acids by use of microorganisms
HUT48888A (en) Process for producing derivatives of neopodophyllotoxin
HUT45727A (en) Process for production of vinilchlorid by thermic splitting of 1,2-dichlor-ethan
CS274677B2 (en) Method of 7-piperazino-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxyl acid's derivatives production
GB2214914B (en) Method for production of glucose by use of transglucosidase
HUT43992A (en) Process for production of crystalline metall-gluconates
DE3785266D1 (de) Stamm zur massenproduktion von epsilon-poly-l-lysin, methode, um diesen stamm zu gebrauchen, und methode zur herstellung von epsilon-poly-l-lysin.
HUT48571A (en) Process for production of substituated 3,5-dichlor-2,4-difluor-benzol
ATE34176T1 (de) 2'-chloropentostatin, eine diese verbindung enthaltende pharmazeutische zusammensetzung und ein mikroorganismus zur herstellung dieser verbindung.
EP0313297A3 (en) Process for production of avermectin aglycones and cultures therefor
HUT48614A (en) Process for producing desmalonyl derivatives of macrolide lactones
HU902500D0 (en) Process for producing intermediaries of n,n'-diacyl-aminales
CA2131284A1 (fr) Mode de production d'avermectines et cultures necessaires a cette fin
HUT45980A (en) Process for production of derivatives of 5-hidroxi-pgf-below-alpha-1,5-lactone
YU43881B (en) Process for obtaining crystalline salt of s-6-fluor-4-(benzyloxi-carbonylamino )chroman-4-carbonic acid
HUT46366A (en) Process for the microbiological production of 1,2-dehydro-steroids
HUT48280A (en) Process for production of starch-2,3,/dihydroxi-prophile/-ether
NZ223910A (en) 2',3'-dideoxynucleosides, process for their production and intermediates therefor
HUT44473A (en) Process for production of 1,2-dietoxi-benzol
HUT47924A (en) Process for production of derivatives of 1,5-benzotiasepine
PL250235A2 (en) Process for preparing 2,5-dinitrate of 1,4:3,6-dianhydro-d-sorbite
HUT44496A (en) Improved process for production of 1-methil-piperidine-2-carbonic acid-/-2,6-dimethil-anilid/

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired
EXP Patent expired